期刊文献+

肛周平滑肌瘤伴发肛瘘1例 被引量:3

下载PDF
导出
摘要 皮肤平滑肌瘤是皮肤平滑肌的良性肿瘤,可由血管平滑肌、立毛肌及乳房或阴囊的平滑肌发展而来,好发于颈面、四肢侧面及会阴部等,但极少发生于肛周。本文报道了1例我们在临床过程中遇到的肛周平滑肌瘤伴发肛瘘的罕见病例,该病例由上海中医药大学附属龙华医院肛肠科门诊初步诊断为"肛瘘"收入院。入院后予以"肛瘘切开引流术",术后送检标本石蜡病理诊断怀疑肛周胃肠外间质瘤,最终确诊为肛周平滑肌瘤,因病例特殊,故予以报道。
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2018年第1期134-136,共3页 Fudan University Journal of Medical Sciences
基金 "十二五"国家科技支撑计划项目(2015BAI04B00) 上海市教育委员会资助项目(2014YSN36) 国家自然科学基金面上项目(81303100)~~
  • 相关文献

参考文献3

二级参考文献54

  • 1包芸,唐峰,王虹,胡锡琪.胃神经纤维瘤:1例报告及文献复习[J].复旦学报(医学版),2005,32(3):352-354. 被引量:4
  • 2贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 3Li J,Gong FJ,Shen L,et al.Post-operative imatinib in patients with intermediate or high risk gastrointestinal stromal tumour[J].Euro J Sur Oncol,2011,37(4):319-324.
  • 4Corless CL,Ballman KV,Antonescu C,et al.Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST):Results of the intergroup phase Ⅲ trial ACOSOG Z9001[J].J Clin Oncol,2010,28 (15 Suppl):a10006.
  • 5Joensuu H,Eriksson M,Hartmann J,et al.Twelve vs 36 months of adjuvant imatinib as treatment of operable GIST with a high risk of recurrence:final results of a randomized trial (SSGXⅧ/AIO)[J].J Clin Oncol,2011,29(Suppl):aLBAI.
  • 6DeMatteo RP,Owzar K,Antonescu CR,et al.Efficacy of adjuvant imatinib mesylate following complete resection of localized,primary gastrointestinal stromal tumor (GIST) at high risk of recurrence:The U.S.Intergroup phase Ⅱ trial ACOSOG Z9000[C/OL].2011[2011-07-29].http://www.anco.org/ascov2/Meetings/Abstracts? &vmview = abst-detail-view&confID =53&abstractID = 10450.
  • 7Demetri GD,von Meherm M,Blanke CD,et al.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J].N Engl J Med,2002,347(7):472-480.
  • 8Zalcberg JR,Verweij J,Casali PG,et al.Outcome of patients with advanced gastrointestinal stromal tumours croasing over to a daily imatinib dose of 800 mg after progression on 400 mg[J].Eur J Cancer,2005,41 (12):1751-1757.
  • 9Rios M,Lecesne A,Bui B,et al.Interruption of imatinib (IM)in GIST patients with advanced disease after one year of treatment:Updated results of the prospective French Sarcoma Group randomized phase Ⅲ trial on long term survival[J].J Clin Oncol,2007,25(18 Suppl):10016.
  • 10Raut CP,Posner M,Dessi J,et al,Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors[J].J Clin Oncol,2006,24(15):2325-2331.

共引文献331

同被引文献12

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部